Brazil China Japan RussiaSpain

Webinar: Accurate Prediction of On- and Off-target Cardiotoxicity with Human iPSC-Derived Cardiomyocytes

Cellular Dynamics International recently hosted a webinar on the use of iPSC-Derived cardiomyocytes in prediction cardiotoxicity. In the presentation Dale Baker, Scientist II in Exploratory Toxicology at Celgene, discusses research that tested kinase inhibitors in Cyprotex’s eCiphr®Cardio assay using iPSC-derived cardiomyocytes and MEA technology. Data presented show how hERG and eCiphr®Cardio together are able to accurately predict dog in vivo outcome and how eCiphr®Cardio is used as functional confirmation of hERG effects.